ThursdayDec 06, 2012 9:57 am

Premier Biomedical, Inc. (BIEI) Announces Breakthrough in Cancer Research

Premier Biomedical has announced successful advances in cancer-focused research. The company’s researchers have successfully killed a cancer tumor in a test tube by simply removing crucial molecular compounds that are necessary for the cancer’s development. They accomplished this by utilizing the Felder Doctrine, which states: “Physically remove the pathophysiologic basis of the disease.” Currently used methods for treating cancer, like chemotherapy and many conventional cancer-fighting drugs, are able to target only one single antigen, which permits another antigen to survive the treatment and allows the cancer to progress. Additionally, these blockers or inhibitors are frequently accompanied by dangerous side effects…

Continue Reading

WednesdayDec 05, 2012 2:33 pm

iBio, Inc. (IBIO) R&D Collaborator Awarded Contract from the National Institute of Health

iBio develops and offers product applications of its proprietary iBioLaunch and iBioModulator platforms, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products. The iBioLaunch platform is technology for the development and production of biologics using transient gene expression in unmodified green plants. The iBioModulator is complementary to iBioLaunch and enables significantly improved vaccine products with higher potency and greater duration of effect. The company announced today that the National Institute of Allergy and Infectious Diseases (part of the National Institute of Health) has awarded a contract to one of iBio’s collaborators, the Fraunhofer…

Continue Reading

WednesdayDec 05, 2012 2:33 pm

iBio, Inc. (IBIO) R&D Collaborator Awarded Contract from the National Institute of Health

iBio develops and offers product applications of its proprietary iBioLaunch and iBioModulator platforms, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products. The iBioLaunch platform is technology for the development and production of biologics using transient gene expression in unmodified green plants. The iBioModulator is complementary to iBioLaunch and enables significantly improved vaccine products with higher potency and greater duration of effect. The company announced today that the National Institute of Allergy and Infectious Diseases (part of the National Institute of Health) has awarded a contract to one of iBio’s collaborators, the Fraunhofer…

Continue Reading

WednesdayDec 05, 2012 2:33 pm

Vanguard Energy Corp. (VNGE) Independent Report Shows 17% Growth in Proven Reserves

Vanguard Energy, the drilling and production company focused on established fields in southeast Texas, reported today that the third party reserve engineering firm used for certification purposes has upwardly revised the final proved reserves total by 17% to 725,882 bbls, firmly reinforcing the value of Vanguard’s flagship Batson Dome Field, as well as the company’s extant/new drilling program(s). This is an even larger jump when compared to last year’s exit totals (reserves are up 20% since Sept 30), a track record that clearly shows VNGE’s capacity to grow reserves through circumspect development. We are talking a PV-10 value of some…

Continue Reading

WednesdayDec 05, 2012 2:32 pm

Monster Offers (MONT) Merges with Ad Shark to Form Enhanced Mobile Advertising Products and Solutions

Monster Offers and Ad Shark today announced that they have completed a merger of the two companies to create the emerging entity Newco, which will continue trading under the ticker symbol “MONT.” Monster Offers and Ad Shark each deliver targeted mobile advertising services and marketing programs. The companies suggested that they are mulling a potential new name for Newco to better reflect brands and market opportunities resulting from their merger. “We are very pleased and excited to have this merger completed,” Wayne Irving, II, CEO of Monster Offers stated in the press release. “As the company moves forward, we will…

Continue Reading

WednesdayDec 05, 2012 10:56 am

Follow QualityStocks on Twitter!

The equity markets are constantly moving and it is imperative that an active trader can find out what is happening in real-time. Even if you aren’t trading all day long – it is important to stay on top of the latest-breaking news. That is why we created our Twitter account just for you. By following us at Twitter, you will be right on top of the action in the micro-cap and small-cap markets. You will receive short alerts regarding stock movements, news releases, and our new “Ones to Watch.” Every week we send dozens of tweets to bring our followers…

Continue Reading

WednesdayDec 05, 2012 7:48 am

AXION International Holdings, Inc. (AXIH) STRUXURE™ Products Used on First-of-its-Kind Bridge in California

AXION International Holdings, Inc. (AXIH) STRUXURE™ Products Used on First-of-its-Kind Bridge in California AXION International Holdings president and CEO Steve Silverman later this week is scheduled to attend a ribbon cutting ceremony for the opening of the first bridge in California to be constructed out of AXION’s STRUXURE™ building products. AXION, a green technology company transforming waste plastics into structural building materials, provided its STRUXURE building material for the 25-foot pedestrian bridge in Santa Rosa Valley, Calif. The 25-foot pedestrian bridge is the first known bridge on the West Coast with a superstructure and fencing made of recycled plastic. Though…

Continue Reading

WednesdayDec 05, 2012 7:47 am

SciClone Pharmaceuticals, Inc. (SCLN) New ZADAXIN Anti-Counterfeiting Label Receives Prestigious Industry Award

SciClone Pharmaceuticals announced that in the annual competition sponsored by the Tag and Label Manufacturers Institute (TLMI), its newly created anti-counterfeiting Pharma-Comb Void label for ZADAXIN has won the prestigious “Innovator Award.” Created for SciClone by Schreiner MediPharm, a developer and manufacturer of pharmaceutical specialty labels based in Germany, the ZADAXIN label has been designed based on an innovative multipart concept to ensure product safety and security, as well as to counteract the illegal practice of refilling previously used medicine vials. The serious problem of drug counterfeiting is a challenge facing the pharmaceutical industry, public health and regulatory authorities throughout…

Continue Reading

WednesdayDec 05, 2012 7:46 am

The Guitammer Company, Inc. (GTMM) Executive Provides Comprehensive Overview of the Company and Its Exciting Prospects

Mark Luden, President and CEO of The Guitammer Company, was recently introduced by Singular Research, a trusted supplier of performance-based research on micro-cap companies. Mark Luden had presented at Singular’s 7th Annual “The Best Of The Uncovereds” conference, making a big hit with a product demonstration. The Guitammer Company, based in Ohio, is a leader in low frequency sound products and technology, with award-winning innovations through their ButtKicker brand, that let users feel low-frequency sound in ways never before possible. The frequencies they work with are below the audible level, so the user doesn’t hear the sound, but actually feels…

Continue Reading

TuesdayDec 04, 2012 2:38 pm

Biostar Pharmaceuticals, Inc. (BSPM) Signs $8 Million Agreement to Supply Xijing Military Hospital with 16 New Drugs

Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions in China, today announced that the company, on November 26, 2012, signed another one-year agreement with Xijing Military Hospital valued at approximately $8 million. The agreement requires that Biostar manufacture and supply Xijing Military Hospital with 16 new drugs used to treat an array of diseases such as pharyngitis, nasopharynx, gastroenteropathy, nephropathy, asthma, hyperplasia of mammary glands, dermatosis, gynecological diseases, etc. The material terms of this agreement are comparable to the previous two one-year agreements Biostar signed with the same…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered